In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis

Ann N Y Acad Sci. 1996 Feb 13;778:390-2. doi: 10.1111/j.1749-6632.1996.tb21153.x.
No abstract available

MeSH terms

  • Administration, Oral
  • Animals
  • Dose-Response Relationship, Drug
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / prevention & control*
  • Female
  • Immunity, Mucosal
  • Injections, Subcutaneous
  • Interferon-gamma / biosynthesis
  • Interleukin-10 / biosynthesis
  • Interleukin-4 / administration & dosage
  • Interleukin-4 / therapeutic use*
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred Strains
  • Myelin Basic Protein / administration & dosage
  • Myelin Basic Protein / immunology
  • Transforming Growth Factor beta / biosynthesis*

Substances

  • Myelin Basic Protein
  • Transforming Growth Factor beta
  • Interleukin-10
  • Interleukin-4
  • Interferon-gamma